Maynard Um
-
-
-
-
-
-
-
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025
-
-
-
-
-
-
-
Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
-
-
-
-
-
-
-
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

